20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME
#602STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF
#603COMPOSITIONS AND METHODS OF TREATING DRY EYE SYNDROME AND OTHER TRAUMATIZED NON-KERATINIZED EPITHELIAL SURFACES
#604NON-STOP PRODUCTION PROCESS FOR IMPROVING FREEZE-DRYING SURVIVAL, HEAT TOLERANCE, SHELF STABILITY AND DIGESTIVE STABILITY OF PROBIOTICS USING SPONTANEOUS MATRIX-ENCAPSULATION TECHNIQUE
#605SWINE ORIGIN PROBIOTICS THAT PROMOTE HEALTH AND GROWTH PERFORMANCE IN PIGS
#606TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A TNF INHIBITOR
#607FACTOR IX POLYPEPTIDE FORMULATIONS
#608COMPOSITIONS COMPRISING BACTERIAL STRAINS
#609Microbiota restoration therapy (MRT) compositions and methods of manufacture
#610High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients
#611METHOD OF MAKING LYOPHILIZED PROTEIN FORMULATIONS
#612CO-LYOPHILIZED RNA AND NANOSTRUCTURED LIPID CARRIER
#613SOL-GEL COMPOSITION
#614COMPOSITIONS COMPRISING BACTERIAL STRAINS
#615FREEZE DRIED LOW HYGROSCOPICITY ACTIVE POWDER COMPOSITIONS
#616PHARMACEUTICAL COMPOSITIONS IN LYOPHILIZED FORM
#617Lyophilized Formulations of AAV Drug Products
#618Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-delta5NSP3
#619Use of C-type natriuretic peptide variants to treat skeletal dysplasia
#620LACTOBACILLUS FORMULATIONS WITH IMPROVED STABILITY AND EFFICACY
#621PHARMACEUTICAL COMPOSITION OF AQUAPORIN INHIBITOR AND PREPARATION METHOD THEREOF
#622INTRAVENOUS GANAXOLONE FORMULATIONS AND METHODS OF USE IN TREATING STATUS EPILEPTICUS AND OTHER SEIZURE DISORDERS
#623SINGLE VIAL VACCINE FORMULATIONS
#624POLYPEPTIDES
#625RECONSTITUTABLE TEVERELIX-TFA COMPOSITION
#626PHARMACEUTICAL COMPOSITION BASED ON PLANT EXTRACTS FOR THE TREATMENT OF FIBROMYALGIA, RHEUMATOID ARTHRITIS, LUPUS AND OTHER AUTOIMMUNE DISEASES
#627RAPIDLY INFUSING PLATFORM AND COMPOSITIONS FOR THERAPEUTIC TREATMENT IN HUMANS
#628FREEZE-DRIED EXOSOME COMPOSITION AND USES THEREOF
#629JANUS FINE PARTICLE AND METHOD FOR PRODUCING SAME
#630NOVEL BISPECIFIC ANTI-CD3/CD20 POLYPEPTIDE COMPLEX FORMULATION
#631STABLE FORMULATIONS OF CYTOMEGALOVIRUS
#632WHOLE BACTERIA CAPSULE, PREPARATION METHOD THEREFOR AND USE THEREOF
#633VEILLONELLA PARVULA STRAIN AS AN ORAL THERAPY FOR NEUROINFLAMMATORY DISEASES
#634EXOSOME COMPOSITION AND METHOD OF MANUFACTURE
#635NOTCH SIGNALING INHIBITORS FOR TREATING OBESITY AND METABOLIC DISORDERS
#636SIROLIMUS MICROSPHERES AND METHOD OF MAKING SIROLIMUS MICROSPHERES
#637INTESTINAL ALKALINE PHOSPHATASE FORMULATIONS
#638NANO-EMULSION OF CBFß-RUNX1 INHIBITOR FOR OCULAR DRUG DELIVER
#639SOLUTION PREPARATION CONTAINING STABILIZED ANTIBODY
#640STABLE FORMULATION FOR RECOMBINANT ANTI-PD-1 MONOCLONAL ANTIBODY
#641ANTI-BTN3A ANTIBODIES AND THEIR USE IN TREATING CANCER OR INFECTIOUS DISORDERS
#642Formulation, Dosage Regimen, and Manufacturing Process for Heterodimeric FC-Fused Proteins
#643LOW-DOSE PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
#644FORMULATIONS COMPRISING ACTRII POLYPEPTIDE VARIANTS
#645PREPARATION METHOD OF SALFAPRODIL FREEZE-DRIED POWDER INJECTION, AND PRODUCT AND USE THEREOF
#646STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF
#647Pharmaceutical composition, package and method for producing the same
#648PROTEASE COMPOSITION
#649CIS-Binding Siglec Agonists and Related Compositions And Methods
#650Therapeutic bacteriophage compositions for treating infection
#651PLATELETS LOADED WITH ANTI-CANCER AGENTS
#652METHOD FOR OBTAINING A MAMMALIAN CELL LINE THAT EXPRESSES A RECOMBINANT EQUINE CHORIONIC GONADOTROPIN (RECG), THE RECOMBINANT CELL LINES PRODUCING RECG, LARGE-SCALE RECG PRODUCTION METHOD, RECG, FORMULATIONS CONTAINING RECG, NUCLEIC ACIDS ENCODING FOR RECG AND USES
#653METHOD OF USING HIGH-FREQUENCY SOUND WAVES
#654Adeno-associated virus formulations
#655METHOD OF TREATING CANCER
#656Assembly, apparatus and method for lyophilization
#657METHOD OF MANUFACTURING AN EMBOLIZING AGENT PRECURSOR
#65817Beta-ESTRADIOL/VITAMIN C MOLECULAR COMPLEX, PREPARATION METHOD, AND USE THEREOF
#659Freeze-Dried Composition
#660Saposin C pharmaceutical compositions and methods of treating cancer
#661LYOPHILIZED FORMULATION CONTAINING CEPHALOSPORIN HAVING CATECHOL GROUP AND THE MANUFACTURING METHOD
#662RNA VACCINES
#663METHOD OF IMAGING
#664IMMUNOGENIC COMPOSITIONS AGAINST CLOSTRIDIOIDES (CLOSTRIDIUM) DIFFICILE AND METHODS THEREOF
#665AMNIOTIC FLUID TOPICAL FORMULATION
#666PHARMACEUTICAL AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA
#667SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES
#668ANTIBODY-CONTAINING FORMULATION
#669Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events
#670FORMULATIONS OF BRINCIDOFOVIR
#671Freeze-dried alginic acid preparation
#672NOVEL SKIN CARE COMPOSITION
#673AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME
#674BACTERIUM OF THE CHRISTENSENELLACEAE FAMILY IN THE PREVENTION AND/OR TREATMENT OF HYPERTRIGLYCERIDEMIA
#675A PARTICLE ENCAPSULATING HYDROPHILIC OR AMPHIPHILIC BIOLOGICAL COMPOUNDS
#676Formulations of tegavivint
#677METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE
#678ANTIBODY AND PROTEIN FORMULATIONS
#679Composition containing a somatostatin analogue for radiopharmaceutical use
#680FORMULATION OF PURE DIMETHOXY CURCUMIN-HUMAN SERUM ALBUMIN AND A PROCESS FOR THE PREPARATION THEREOF
#681BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 AND USES THEREOF
#682INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#683Diketopiperazine Microparticles with Defined Specific Surface Areas
#684CONCENTRATED COMPOSITIONS OF PROTEINS, THEIR PREPARATION AND USE THEREOF
#685Lyophilized Live Bordetella Vaccines
#686NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#687FORMULATION CONTAINING HMGB1 PARTIAL PEPTIDE
#688Physiologically balanced injectable formulations of fosnetupitant
#689VIRAL VECTOR STABILIZATION
#690METHOD OF LYOPHILIZING LIPOSOMES
#691PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY DRUG CONJUGATE AND USE THEREOF
#692Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
#693CNS DELIVERY OF THERAPEUTIC AGENTS
#694TREATMENT OF RESPIRATORY TRACT DISEASES AND INFECTIONS WITH ASCORBIC ACID COMPOSITIONS
#695CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS
#696COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#697COMPOSITIONS COMPRISING BACTERIAL STRAINS
#698TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6- DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE
#699Nanoparticle vaccine adjuvant and methods of use thereof
#700Lyophilized compositions of phenobarbital sodium salt
#701Lyophilization of RNA
#702Antibodies to Symmetrically Dimethylated Arginine Analytes and Use Thereof
#703Long lasting effect of new botulinum toxin formulations
#704PLATELET DERIVATIVE COMPOSITIONS, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS
#705TETRAZOLE DERIVATIVES
#706METHOD OF MANUFACTURING PEPTIDE NANOPARTICLES
#707Injectable and inhalable formulations
#708COMPOSITION COMPRISING TRABECTEDIN AND AN AMINO ACID
#709PREPARATION METHOD OF THERMOSENSITIVE GEL FOR TREATING ANDROGENETIC ALOPECIA
#710Reconstituted HDL formulation
#711A stabilized protein of interest.
#712C-type natriuretic peptide variants to treat skeletal dysplasia in children
#713OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS
#714Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and sodium ions
#715LYOPHILIZED REAGENTS
#716LONG-ACTING APOMORPHINE FORMULATIONS AND INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME
#717METHOD FOR TREATING LUNG DISEASE WITH CELL-FREE AMNIOTIC FLUID
#718METHOD FOR SCREENING FOR, METHOD FOR PRODUCING, AND METHOD FOR DESIGNING DRUG ACTIVE INGREDIENTS
#719LYOPHILISATION PROCESS
#720Methods and compositions for the treatment of C. difficile
#721FORMULATIONS OF ANTI-ENDOTHELIAL LIPASE ANTIBODIES
#722Stabilized liquid and lyophilized ADAMTS13 formulations
#723ANTHELMINTIC COMPOSITIONS AND METHODS
#724Thermo-responsive hydrogel for intratumoral administration as a treatment in solid tumor cancers
#725CELL-TARGETED NANOPARTICLES TO INHIBIT RNA CARGO
#726DRIED PARTICLE INHALATION FOR DELIVERY OF CANNABIS
#727NOVEL POLYINOSINIC - POLYCYTIDYLIC ACID COMPOSITIONS AND METHODS OF MAKING SAME
#728DRY POWDER COMPOSITIONS OF OIL-IN-WATER (O/W) EMULSION ADJUVANTED VACCINES
#729CANINE BLOOD PLATELET PREPARATIONS
#730SYSTEMS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT BY DIRECT INJECTION OF A TARGETED POPULATION OF CELLS
#731PHARMACEUTICAL COMPOSITION COMPRISING BISPECIFIC ANTIBODY CONSTRUCTS
#732LIVE-PATHOGEN-MIMETIC NANOPARTICLES BASED ON PATHOGEN CELL WALL SKELETON, AND PRODUCTION METHOD THEREOF
#733NANO-COMPOSITE MICROPARTICLES OF POLYMYXIN
#734Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and pharmaceutical compositions thereof
#735COMPOSITION OF MATTER AND METHODS FOR A FECAL-DERIVED STERILIZED PREBIOTIC AND POSTBIOTIC
#736NOVEL POLYINOSINIC - POLYCYTIDYLIC ACID COMPOSITIONS
#7373D PRINTED, FREEZE-DRIED HYDROGELS AND METHODS OF MAKING AND USING THE SAME
#738SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES
#739OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF
#740Target residual moisture content for lyophilized drug product
#741Multi chamber flexible bag and methods of using same
#742METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION
#743MICROBIOME DELIVERY PLATFORM
#744DAPTOMYCIN FORMULATION
#745COMPOSITIONS AND FORMULATIONS INCLUDING CABAZITAXEL AND HUMAN SERUM ALBUMIN
#746Collagen-based therapeutic delivery systems
#747Poly(beta-amino esters) and uses thereof
#748Formulations of dengue virus vaccine compositions
#749Soluble melatonin tripartate adduct for the prevention and treatment of rare and severe eye sight-threatening conditions and neuro-ophthalmic disorders
#750Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes
#751RESINIFERATOXIN COMPOSITIONS
#752PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS
#753PROGRAMMED CELL DEATH RECEPTOR 1 ANTIBODY FORMULATION AND USE THEREOF
#754STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS
#755PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ALZHEIMER'S DISEASE USING PHYTIC ACID AND PHYTATE TO REDUCE AMYLOID BETA PLAQUE AND TAU PROTEIN
#756HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF
#757Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
#758PHARMACEUTICAL FORMULATIONS OF TNF-ALPHA ANTIBODIES
#759UNIVERSAL ORAL DELIVERY DEVICE OF INTACT THERAPEUTIC POLYPEPTIDES WITH HIGH BIOAVAILABILITY
#760CAPSULE COMPRISING A FAECAL COMPOSITION
#761IGG:TGFBETARII FUSION PROTEIN COMPOSITION
#762Methods for making compositions for pulmonary administration
#763Microparticle Enabled Delivery Structures, Methods of Preparing and Using Same
#764Formulations for Enteric Delivery of Therapeutic Agents
#765Stabilization of phenobarbital sodium for injection
#766Freeze-Dried Preparations Comprising Megakaryocytes and Platelets
#767METHOD OF STERILIZATION OF BIOLOGICS
#768Methods and compositions for CNS delivery of iduronate-2-sulfatase
#769BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 AND USES THEREOF
#770STABLE COMPOSITIONS OF FC MULTIMERS
#771Method for Manufacturing a Fibrinogen Preparation
#772USE OF MALTODEXTRIN AS AN EXCIPIENT
#773BIOLOGIC PRESERVING COMPOSITION AND METHODS OF USE
#774Hemostatic nanocapsules for stopping bleeding, visualizing injury, and delivering drugs
#775INHALABLE DRY POWDER AND AEROSOL FORMULATIONS OF JAK INHIBITORS
#776NEW SOLID STATE FORM OF LURBINECTEDIN
#777WATER-DISPERSIBLE DRY POWDER FORMULATION AND PRODUCTION METHOD THEREOF
#778METHODS OF SUPPORTING A GRAPHENE SHEET DISPOSED ON A FRAME SUPPORT
#779Thermostable Vaccine Compositions and Methods of Preparing The Same
#780PROTEIN FORMULATIONS AND METHODS OF MAKING SAME
#781BIODEGRADABLE POLYMERIC COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF
#782Insulin formulations and methods of using same in preterm infants
#783FREEZE-DRIED POWDER CONTAINING 2-[(3-AMINOPROPYL)AMINO]ETHANETHIOL AND ITS USE FOR PREPARING A THERMOGEL
#784Process for preparing microparticles containing glatiramer acetate
#785CANNABINOID NANOMICELLE PREPARATION AND METHOD FOR PREPARING SAME
#786PROCESS FOR THE PREPARATION OF DISPERSIONS COMPRISING INHALABLE IMMUNOSUPPRESSIVE ACTIVE INGREDIENTS
#787System and method for virtual image adjustment
#788FREEZE-DRIED COMPOSITION FOR PREPARING CALIBRATED GAS-FILLED MICROVESICLES
#789In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)
#790Freeze dried drug nanosuspensions
#791Solid Δ-tetrahydrocannabinol (Δ-THC) compositions
#792STABLE PARENTERAL FORMULATIONS OF DULOXETINE
#793Inhalable antimicrobial particles and methods of making the same
#794LYOPHILIZED CAKE IN STRAIGHT-WALLED VIAL
#795PARTICULATE LYOPHILIZED PLATELET LYSATE COMPOSITIONS
#796SOLID FORMS OF OMECAMTIV MECARBIL DIHYDROCHLORIDE AND PROCESSES THEREOF
#797Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders
#798IMMUNOGENIC COMPOSITION
#799SOLID PARTICLES CONTAINING SOLID PRIMARY PARTICLES THAT CONSIST ESSENTIALLY OF NATIVE CELLULOSE
#800IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY
#801CRYSTALLINE FORMS OF A BIPHENYL COMPOUND
#802TRANS CAROTENOIDS, THEIR SYNTHESIS, FORMULATION AND USES
#803PEPTIDE VACCINE BASED ON A NEW UNIVERSAL INFLUENZA A HEMAGGLUTININ HEAD DOMAIN EPITOPE AND HUMAN MONOCLONAL ANTIBODIES BINDING THERETO
#804COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME
#805Microparticles and nanoparticles having negative surface charges
#806ALBUMIN-PD-1 PACLITAXEL NANOPARTICLE COMPLEX COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#807METHODS, COMPOSITIONS, AND VACCINES FOR TREATING A VIRUS INFECTION
#808CRIZANLIZUMAB CONTAINING ANTIBODY FORMULATIONS
#809DRY POWDER FORMULATIONS OF TAMIBAROTENE FOR PULMONARY AND INTRANASAL DELIVERY
#810USES OF IL-13 ANTAGONISTS FOR TREATING ATOPIC DERMATITIS
#811Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
#812FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY
#813ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS
#814PHARMACEUTICAL COMPOSITION AND FUNCTIONAL HEALTH FOOD FOR TREATING BENIGN PROSTATIC HYPERPLASIA INCLUDING LAURUS NOBILIS AS ACTIVE INGREDIENT, AND METHOD OF TREATING BENIGN PROSTATIC HYPERPLASIA USING THE SAME
#815NANOPARTICLE ISOFLAVONE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#816High concentration formulations of anti-CSF1 and anti-CSF1R antibodies
#817PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING ACTIVE SUBSTANCE, POLYMER AND SURFACTANT
#818Polyomavirus neutralizing antibodies
#819Recombinant varicella-zoster virus (VZV) vaccine
#820METHOD FOR COATING AND DRYING HETEROGENOUS STEM CELL DERIVED EXTRA-CELLULAR VESICLES
#821NOVEL PHARMACEUTICAL FORMULATION
#822NEW HYDROCORTISONE HEMISUCCINATE LYOPHILIZATE
#823METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE
#824Freeze-dried product and gas-filled microvesicles suspension
#825Lyophilized Compositions of Phenobarbital Sodium Salt
#826LIPID NANOPARTICLE LYOPHILIZED COMPOSITION
#827Lyophilized formulations for factor XA antidote
#828Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
#829Composition comprising probiotics and polypeptide having binding affinity for IgE and use thereof
#830METHODS FOR THE TREATMENT OF THYROID EYE DISEASE
#831BIODEGRADABLE POLYMERIC COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF
#832STABLE FORMULATIONS OF RECOMBINANT PROTEINS
#833COMPOSITIONS COMPRISING BACTERIAL SPECIES AND METHODS RELATED THERETO
#834POLYPEPTIDE FORMULATIONS
#835Animal protein-free pharmaceutical compositions
#836Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
#837PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#838BIODEGRADABLE POLYMERIC PARTICLES ENCAPSULATING AN ACTIVE AGENT, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#839Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
#840Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR
#841Lyophilized preparation of cytotoxic dipeptides
#842Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
#843COMPOSITION WITH DRUG MICRO-NANO PARTICLES OF AN ANTI-CANCER AGENT
#844FORMULATION FOR ADMINISTRATION OF RNA
#845Methods of treating spinal cord injury
#846Polylactic acid microsphere, polylactic-co-glycolic acid microsphere and method of preparing the same
#847IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS
#848STABILIZING BUFFER FOR FACTOR VIII AND VWF
#849PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFOR
#850BENDAMUSTINE COMPOSITION AND USE THEREOF
#851LYOPHILIZED POWDER OF LATAMOXEF SODIUM FOR INJECTION AND LYOPHILIZATION METHOD THEREOF
#852METHODS AND FORMULATIONS FOR REDUCING RECONSTITUTION TIME OF LYOPHILIZED POLYPEPTIDES
#853METHACRYLATED COLLAGEN
#854RADIOPHARMACEUTICAL COMPOSITIONS OF RADIOACTIVE HALOGENATED BENZYLGUANIDINE
#855Highly concentrated formulations of soluble Fc receptors
#856Compositions and methods for promoting a healthy microbial flora in a mammal
#857Stable liquid formulations of cyclophosphamide and processes to prepare the same
#858Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same
#859PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION IN POWDER FORMULATION CONTAINING ANTIVIRAL AGENT
#860Small Molecule Agents, Compositions, and Formulations, for Internal Use, Displaying Inhibitory Activity Against Gram-positive and/or Gram-negative Organisms
#861Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
#862Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
#863A STABLE LYOPHILIZED FORMULATION FOR HYBRID FC FUSED G-CSF
#864NANOENCAPSULATED CANNABIDIOL
#865Compositions and methods for removing bio-synthetic nano-particles from bodily fluids
#866Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
#867LOW-SORBING GLYBURIDE FORMULATION AND METHODS
#868CAPSULE PROTEIN AND MULTIMERIC COMPLEX COMPOSITION THEREOF, AND PHARMACEUTICAL COMPOSITION USING SAME
#869DOTMP kit formulations for radioisotopes
#870CONJUGATES FOR USE IN METHODS OF TREATING CANCER
#871LYOPHILIZED ANTIBODY FORMULATION
#872FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTIPLATELET INDUCED COAGULOPATHY
#873Dendrimer formulations
#874POWDERED PLANT PREPARATION, THE MANNER IN WHICH IT IS OBTAINED, MICROGRANULES AND TABLETS OBTAINED FROM THAT PREPARATION AND THE WAYS OF PRODUCING THEM
#875COSMETIC COMPOSITION CONTAINING GRAPHENE QUANTUM DOTS AS ACTIVE INGREDIENT
#876CELL CULTURE METHODS AND COMPOSITIONS FOR ANTIBODY PRODUCTION
#877Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methods
#878PEGYLATED CYSTATHIONINE BETA SYNTHASE FOR ENZYME THERAPY FOR TREATMENT OF HOMOCYSTINURIA
#879ENHANCEMENT OF SKELETAL MUSCLE STEM CELL ENGRAFTMENT BY DUAL DELIVERY OF VEGF AND IGF-1
#880SALUTARY EFFECTS OF INDIGENOUS PROBIOTICS AND NANOAEROSOL METHODS TO MITIGATE MICROBIAL INFECTIONS INCLUDING COVID 19
#881COMPOSITIONS COMPRISING BACTERIAL STRAINS
#882METHOD FOR TREATING STROKE BY USING TRICYCLIC DERIVATIVE
#883ANTIMICROBIAL COMPOSITIONS
#884USE OF BIPOLAR TRANS CAROTENOIDS WITH CHEMOTHERAPY AND RADIOTHERAPY FOR TREATMENT OF CANCER
#885METHODS AND ASSEMBLIES FOR PREPARING AND DISPENSING LYOSPHERES OF PHARMACEUTICAL COMPOSITIONS
#886ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN
#887BOTULINUM TOXIN TYPE A COMPLEX, AND FORMULATION THEREOF AND USAGE METHOD THEREFOR
#888LYOPHILIZED RECOMBINANT VWF FORMULATIONS
#889STABLE ALBUVIRTIDE COMPOSITIONS
#890POLYMER NANOPARTICLE COMPOSITION FOR DELIVERING VIRUS, AND PREPARATION METHOD THEREFOR
#891COMPOSITIONS COMPRISING BACTERIAL STRAINS
#892COMPOSITIONS COMPRISING BACTERIAL STRAINS
#893Treatment of glaucoma using endothelin receptor antagonists
#894LONG-LASTING FORMULATION CONTAINING RIVASTIGMINE, AND METHOD FOR PREPARING SAME
#895COMPOSITIONS, PROCESSES OF PRODUCTION, STERILIZATION, AND HEALTH-PROMOTING USES OF LYOPHILIZED MILK
#896Polymer excipients for drug delivery applications
#897FORMULATION COMPRISING ANTI-CD47/PD-L1 BISPECIFIC ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
#898PEGylated synthetic KL4 peptide, Compositions and Methods Thereof
#899AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 IN LYOPHILIZED FORM (VARIANTS)
#900A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE